Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05807477 · ClinicalTrials.gov registry record
Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO19)
A clinical trial, sponsored by Nihon Kohden.
- Completed
- Registry status
- 12
- Enrollment target
NCT05807477: Completed study, sponsored by Nihon Kohden.
NCT05807477 is a clinical trial that has completed, run by Nihon Kohden. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05807477 has completed, sponsored by Nihon Kohden.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest.
Primary Outcome
Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter (SpO2i) to that obtained from a blood sample (SRi) and calculating the arithmetic root mean square (Arms) error value as follows: Arms = Square root (sum of n samples of ((SpO2i - SRi) squared) / n)
Interventions
- DEVICE Pulse Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-04-18 |
| Est. Completion | 2024-05-08 |
What the finished NCT05807477 record still lists
NCT05807477 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pulse Oximeter is the first listed.
NCT05807477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05807477 about?
NCT05807477 is a clinical study titled "Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO19)". The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest.
What is the current status of trial NCT05807477?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2023-04-18. Estimated completion is 2024-05-08.
What interventions are being tested in trial NCT05807477?
The interventions under investigation include: Pulse Oximeter (DEVICE).
Who is sponsoring clinical trial NCT05807477?
This trial is sponsored by Nihon Kohden, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI